Načítá se...
Cutaneous Side Effects and Transepidermal Water Loss To Gefitinib: A Study of 11 Patients
INTRODUCTION: Cutaneous side effects caused by epidermal growth factor receptor (EGFR) inhibitors occurred in 45–100% of patients which may lead to therapy modification or interruption. This study aimed to evaluate cutaneous side effects and transepidermal water loss (TEWL) values in non-small cell...
Uloženo v:
| Vydáno v: | Dermatol Ther (Heidelb) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336432/ https://ncbi.nlm.nih.gov/pubmed/28004308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-016-0163-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|